← Leaderboards
Brian James Werth
University Of Washington
$3,108,015
Attributed
$3,933,258
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $696.9K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,933,258 · 2
By mechanism
R01$3,505,758 · 1
R21$427,500 · 1
Top collaborators
- Libin Xu3 shared
Most similar at University Of Washington
Same institution · by research overlap
- Jillian Pintye$10,948,659
- Gail Anderson$2,069,829
- Carey Farquhar$27,772,472
- Taylor Sandison$170,720
- Zachary David Dalebroux$1,962,530
Others in their field
Other Emerging Leaders on “Predisposition”
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Evan Z Macosko · Broad Institute, Inc.$27,675,880
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,188,684
- Paul John Norman · University Of Colorado Denver$12,197,519
- Leonard Freedmand · Leidos Biomedical Research, Inc.$11,639,100
- Vaia Lida Chatzi · University Of Southern California$11,098,078
Research focus
PredispositionSuperbugMutationPhenotypeResistanceStaphylococcus Aureus InfectionInnovationMutantIn VitroPharmaceutical PreparationsMethicillin Resistant Staphylococcus AureusPreventionResistant StrainMass Spectrum AnalysisAntimicrobialGlycopeptidesAllelesLipidsCoupledCell WallDaptomycinDalbavancinGenome SequencingVancomycin
Grant awards (9)
Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$550,162
R01 · FY2025 · AI · contact PI
Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$550,162
R01 · FY2024 · AI · contact PI
Contribution of altered cell envelope metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$550,162
R01 · FY2023 · AI · contact PI
Contribution of altered lipid metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$463,818
R01 · FY2021 · AI · contact PI
Contribution of altered lipid metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$463,818
R01 · FY2020 · AI · contact PI
Contribution of altered lipid metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$463,818
R01 · FY2019 · AI · contact PI
Resistance Selection Potential of the Long Acting Lipoglycopeptides Dalbavancin and Oritavancin$194,375
R21 · FY2019 · AI · contact PI
Contribution of altered lipid metabolism to resistance to cell envelope-targeting antimicrobials in MRSA$463,818
R01 · FY2018 · AI · contact PI
Resistance Selection Potential of the Long Acting Lipoglycopeptides Dalbavancin and Oritavancin$233,125
R21 · FY2018 · AI · contact PI